Escitalopram Oxalate
CAS219861-08-2
Escitalopram Oxalate (CAS 219861-08-2, C22H23FN2O5) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 219861-08-2
- Formula
- C22H23FN2O5
- Mol. weight
- 414.43 g/mol
- Appearance
- white solid
Chemical Specifications
Identifiers
| CAS number | 219861-08-2 |
|---|---|
| Product name | Escitalopram Oxalate |
| Synonyms | (S)-CITALOPRAM |
| Molecular formula | C22H23FN2O5 |
| Molecular weight | 414.43 g/mol |
Physical and chemical properties
| Appearance | white solid |
|---|---|
| Melting Point | 152-153 ( ℃ ) |
| Boiling Point | 212.8 ( ℃ ) |
Applications
Mainly suitable for the treatment of severe depression.
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Escitalopram Oxalate?
The CAS Registry Number of Escitalopram Oxalate is 219861-08-2. Escitalopram Oxalate is also known as (S)-CITALOPRAM.
What is the molecular formula and molecular weight of Escitalopram Oxalate?
The molecular formula of Escitalopram Oxalate is C22H23FN2O5, and its molecular weight is 414.43 g/mol.
What is Escitalopram Oxalate used for?
Mainly suitable for the treatment of severe depression.
How can I request a quotation for Escitalopram Oxalate?
Send an inquiry for Escitalopram Oxalate (CAS 219861-08-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Escitalopram Oxalate
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.